Alumis (ALMS) Profit After Tax (QoQ) (2023 - 2025)

Alumis (ALMS) Profit After Tax (QoQ) (2023 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Alumis 2.32 Bn 2.01 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -193.33%
Sep 30, 2025 -286.70%
Jun 30, 2025 159.94%
Mar 31, 2025 -4.44%
Dec 31, 2024 33.11%
Sep 30, 2024 -150.70%
Jun 30, 2024 -13.36%
Mar 31, 2024 -26.82%
Dec 31, 2023 9.38%
Sep 30, 2023 -19.53%